ArticleBMC medical genomics2022

Correction: Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells.

Jun Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.